BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1977095)

  • 1. Role of arachidonic acid or its metabolites in growth-hormone-releasing factor-induced release of somatostatin from the median eminence.
    Aguila MC; Milenkovic L; McCann SM; Snyder GD
    Neuroendocrinology; 1990 Sep; 52(3):238-42. PubMed ID: 1977095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin dependence of somatostatin release stimulated by growth hormone-releasing factor.
    Aguila MC; McCann SM
    Endocrinology; 1988 Jul; 123(1):305-9. PubMed ID: 2898360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.
    Aguila MC; McCann SM
    Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of galanin on growth hormone-releasing factor and somatostatin release from median eminence fragments in vitro.
    Aguila MC; Marubayashi U; McCann SM
    Neuroendocrinology; 1992 Dec; 56(6):889-94. PubMed ID: 1285434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat growth hormone-releasing factor stimulates cyclic GMP formation and phosphatidylinositol metabolism in the median eminence.
    Aguila MC; Snyder GD; McCann SM
    Life Sci; 1991; 49(1):67-74. PubMed ID: 1675756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane signals mediating neural peptide secretion: role of protein kinase C activators and arachidonic acid metabolites in luteinizing hormone-releasing hormone secretion.
    Negro-Vilar A; Conte D; Valenca M
    Endocrinology; 1986 Dec; 119(6):2796-802. PubMed ID: 3096697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that growth hormone-releasing factor stimulates somatostatin release in vitro via beta-endorphin.
    Aguila MC; McCann SM
    Endocrinology; 1987 Jan; 120(1):341-4. PubMed ID: 2877865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels.
    Aguila MC; Boggaram V; McCann SM
    Brain Res; 1993 Oct; 625(2):213-8. PubMed ID: 7903898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone releasing factor (GRF) increases free arachidonate levels in the pituitary: a role for lipoxygenase products.
    Canonico PL; Speciale C; Sortino MA; Cronin MJ; MacLeod RM; Scapagnini U
    Life Sci; 1986 Jan; 38(3):267-72. PubMed ID: 2867452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of growth hormone release by gastrin-releasing peptide involves somatostatin release.
    Kentroti S; Aguila MC; McCann SM
    Endocrinology; 1988 Jun; 122(6):2407-11. PubMed ID: 2897283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence.
    Capdevila J; Chacos N; Falck JR; Manna S; Negro-Vilar A; Ojeda SR
    Endocrinology; 1983 Jul; 113(1):421-3. PubMed ID: 6134613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRF increases release of growth hormone and arachidonate from anterior pituitary cells.
    Judd AM; Koike K; MacLeod RM
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E438-42. PubMed ID: 2858979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
    Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonate stimulates prolactin release in vitro: a role for the fatty acid and its metabolites as intracellular regulator(s) in mammotrophs.
    Canonico PL; Judd AM; Koike K; Valdenegro CA; MacLeod RM
    Endocrinology; 1985 Jan; 116(1):218-25. PubMed ID: 2981065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid metabolism and prolactin secretion in vitro: a possible role for the lipoxygenase products.
    Canonico PL; Schettini G; Valdenegro CA; MacLeod RM
    Neuroendocrinology; 1983 Sep; 37(3):212-7. PubMed ID: 6413878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin prevents the desensitizing action of growth hormone-releasing factor on growth hormone release.
    Simard J; Lefèvre G; Labrie F
    Peptides; 1987; 8(2):199-205. PubMed ID: 2884644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase-A2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion.
    Bourdeau A; Souberbielle JC; Bonnet P; Herviaux P; Sachs C; Lieberherr M
    Endocrinology; 1992 Mar; 130(3):1339-44. PubMed ID: 1537295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin decreases somatostatin messenger ribonucleic acid levels in the rat periventricular nucleus.
    Aguila MC
    Peptides; 1998; 19(9):1573-9. PubMed ID: 9864065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid metabolism and thyrotropin secretion in vitro.
    Canonico PL; Valdenegro CA; Judd AM; MacLeod RM
    Eur J Pharmacol; 1984 Feb; 98(1):45-52. PubMed ID: 6425068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the glucose-dependent release of growth hormone-releasing factor and somatostatin from superfused rat hypothalami.
    Baes M; Vale WW
    Neuroendocrinology; 1990 Feb; 51(2):202-7. PubMed ID: 1968236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.